IVF failure can be one of the most emotionally difficult experiences during fertility treatment. After weeks of medication, monitoring, egg retrieval, fertilization, embryo development and embryo transfer, receiving a negative pregnancy test can leave patients searching for an explanation.One of the first questions is usually:“Why did my IVF fail?”Unfortunately, there is rarely one simple answer.
Regenerative medicine is attracting increasing attention in fertility care, particularly among women with diminished ovarian reserve, low AMH, poor ovarian response or age-related decline in ovarian function. Three approaches frequently discussed are Platelet-Rich Plasma (PRP), exosome therapy and stem cell therapy. Although all three are associated with regenerative medicine, they are not the same treatment.
Being told that you have diminished ovarian reserve (DOR) can raise many questions. Does it mean that you are running out of eggs? Can you still become pregnant naturally? Does low ovarian reserve mean poor egg quality? Can IVF work with diminished ovarian reserve? And is there anything you can do to improve your fertility?
More women than ever are considering pregnancy in their 40s. For some, this is the first time they have tried to conceive. Others may already have experienced unsuccessful attempts at natural conception or previous IVF cycles. One of the first questions is usually: “Can IVF work after 40?” The answer is yes—IVF after 40 can
For many women trying to conceive after the age of 35 or 40, one question quickly becomes central: Can I improve my egg quality? It is an understandable question. Female fertility gradually declines with age, and this decline becomes more pronounced during the mid-to-late 30s and 40s. However, fertility is complex, and age is only
Receiving a low AMH result can be worrying, particularly if you are trying to conceive or considering IVF. Many women immediately interpret low AMH as meaning that pregnancy is unlikely—or even impossible. But low AMH does not mean that you cannot become pregnant. Anti-Müllerian Hormone (AMH) is primarily a marker of ovarian reserve, helping
Dr. Matthew Fraidakis along with Dr Alexandros Zervakis discussed at the TV show entitled "Sto Kokkino" about the newest technological breakthroughs in the IVF sector. The establishment of a new clinic in Chania brings the high expertise and knowledge of both of them in the city of Chania. Chania Fertility Unit offers all the
Dr. Mattheos Fraidakis, the scientific director both of Chania Fertility Unit and Crete Fertility Centre, attended the the 33rd COGI World Congress in Rome, Italy. At the 33rd COGI World Congress (Controversies in Obstetrics, Gynecology, and Infertility) the topic of "PRP for rejuvenation aimed at improving ovarian response" was successfully discussed. Dr. Matthaios Fraidakis's
Dr. Matthew Fraidakis addresses the newest technological breakthroughs in the field of human assisted reproduction applied at the newly established clinic in Chania named Chania Fertility Unit bringing the expertise, the knowledge and the success of Crete Fertility Centre in Heraklion. See the interview
Dr. Mattheos Fraidakis, the scientific director both of Chania Fertility Unit and Crete Fertility Centre, attended the 2nd SIMA congress, which was held in Heraklion, Crete, on November 21–23, 2025. The Heraklion Medical Association and the Famagusta Medical Association were the organisers of the Congress, inspired by the first recorded reference to a physician
Chania Fertility Unit is in strong collaboration with the well-known IVF clinic Crete Fertility Centre, bringing to Chania all the high quality services and expertise.
CHANIA FERTILITY UNIT
Chania, Crete, Greece
Tel: +3028210 36060 , +3028212 00166
e-mail:info@fertilitychania.gr
© Copyright 2026 All Rights Reserved. Powered by OpenIT
